| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Definitive Healthcare (NASDAQ:DH) reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Definitive Healthcare missed estimated earnings by -12.0%, reporting an EPS of $0.07 versus an estimate of $0.08.
Revenue was up $5.33 million from the same period last year.
Last quarter the company beat on EPS by $0.03 which was followed by a 20.0% increase in the share price the next day.
Here's a look at Definitive Healthcare's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.06 | 0.05 | 0.04 | 0.04 |
| EPS Actual | 0.09 | 0.08 | 0.06 | 0.07 |
| Revenue Estimate | 63.71M | 61.02M | 57.58M | 58.45M |
| Revenue Actual | 65.33M | 60.96M | 59.20M | 60.60M |
To track all earnings releases for Definitive Healthcare visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: DH
